moa of glp-1 agonists Glucagon-like peptide-1 Glucagon-like peptide-1 receptor: mechanisms and

Ozempic (semaglutide) is a medication used to manage type 2 diabetes

(2025) explores current evidence, challenges, and future perspectives in managing surgical patients on GLP-1R agonists

Issue 42 of The Altascientist explores GLP-1 receptor agonist drug development, covering preclinical models, bioanalytical assays, clinical study design, and manufacturing

Obesity is a complex disease characterized by excessive fat accumulation which is caused by genetic, environmental and other factors

DPP-4 inhibitors were introduced for the treatment of type 2 diabetes in 2006

Rare disorders and disease progression were not examined